Emerging contaminants such as pharmaceutical residues, pesticides and even PFAS are coming under intense scrutiny in Europe, laying the foundation for a booming market for advanced treatment technologies. Regulation of emerging contaminants is expected in an update to the Urban Wastewater Treatment Directive, due for adoption by the European Commission in early 2022, while the revised Drinking Water Directive – adopted in 2021 - includes limit values for PFAS and endocrine disruptors. As the regulatory picture continues to develop, some regions of Europe are pressing forward with wastewater treatment projects targeting micropollutants. First-mover Switzerland is rolling out a €1 billion programme to upgrade WWTPs with fourth-stage treatment until 2035, while there has been a growing pipeline of projects in Sweden and Germany. A focus on reducing pollution at source means industrial users must also be part of the solution. GWI is convening a multi-stakeholder meeting to assess the emerging contaminants regulatory landscape and the treatment solutions required to secure the quality of Europe’s waters.
Platform Familiarisation & Introductions
Pioneers; Hear from the first-movers who have been involved in initiatives to meet the emerging contaminants challenge.
Early Adopters; Get an idea of the key regions and strategies central to the next wave of fourth-stage treatment process adoption.
Technology Debate; Get insights on the current technological landscape and innovation trends, exploring how ozone, activated carbon, and other advanced treatment processes can address stricter discharge requirements.
Open Networking Session
Industry experts will take part in three discussion panels highlighting the perspective of the pioneers, the early adopters, and the technology specialists. Each panel will be followed by an Audience Q&A where you can pose your questions to the speakers.
The meeting will end with an open networking portion where you have the opportunity to meet and network directly with speakers and other attendees in small groups.